info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Alopecia Drugs Companies

Several pharmaceutical companies were involved in the development and production of drugs for the treatment of alopecia, a condition characterized by hair loss. Please note that the status of companies and their products may have changed since then.

Alopecia Drugs Market

 


Latest Alopecia Drugs Companies Updates:


Sun Pharma, a leading Indian pharmaceutical company, acquired Concert Pharmaceuticals in October 2023 for $576 million.This move brings Concert's promising oral drug, deuruxolitinib, under Sun Pharma's wing. Deuruxolitinib is in late-stage trials for alopecia areata and could be the first oral treatment approved for the condition in the US.


In July 2023, Pfizer received FDA approval for LITFULO™ (ritlecitinib), the first-ever systemic therapy for severe alopecia areata approved for adults and adolescents aged 12 and above.This oral medication offers new hope for individuals with advanced alopecia areata who haven't responded to topical treatments.


Pfizer is also seeking approval for LITFULO in other countries and for other hair loss conditions like vitiligoLegacy Healthcare, a Swiss biopharmaceutical company, is making waves with its lead drug candidate, Coacillium, for treating moderate to severe alopecia areata in children and adolescents.


Coacillium is a botanical drug derived from a plant extract, offering a potential alternative to existing treatments with potentially fewer side effects.Legacy Healthcare has garnered media attention and is actively participating in clinical trials for Coacillium, raising hopes for a novel treatment option in the future.


List of Alopecia Drugs Key companies in the market:



  • Mylan N.V

  • Aurobindo Pharma

  • GlaxoSmithKline plc

  • Cipla Limited

  • Johnson & Johnson Services

  • Merck & Co. Inc

  • Sun Pharmaceuticals Industries Ltd

  • Dr Reddy's Laboratories Ltd


 


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.